Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 329681
Invention means University#98-14 Sex Related Deference in Pain Relief from Spinal Compound (RJR 2403)
VCU Patents S Patent #5,914,337 – Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
TC-2696 for the treatment of chronic or female-specific pain. TC-2696 is a novel small molecule that we are developing as an oral treatment for acute post-operative pain.
IPSCIO Record ID: 230789
The patents are A Novel Gene Therapy Approach for Controlling Pathological Pain and Opiate Tolerance Spinal Production of the Anti-Inflammatory Cytokine, Interleukin-10, and, Suppression of Pathological Pain Plus Enhancement of Morphine Analgesia with the AntiInflammatory Cytokine Interleukin-10.
IPSCIO Record ID: 344574
— an exclusive, worldwide, license under Licensors rights in Patent Rights to develop, have developed, make, have made, use, have used, sell, have sold, offer for sale, import and have imported Products;
— a non-exclusive, worldwide, license under Licensors rights in Technological Information;
— the right to sublicense Patent Rights exclusively licensed to Licensor.
The patent is titled Methods of decreasing or preventing pain using spicamycin or derivatives thereof.
IPSCIO Record ID: 240632
The license includes the active ingredients in Latranal, a drug for treating pain associated with muscle and tendon injury, from Licensor, which discovered that a topical formulation of two generically available compounds was effective for pain relief.
IPSCIO Record ID: 5599
IPSCIO Record ID: 230815
Licensor shall grant a non-exclusive sublicense of Licensors interests and entitlements solely in the Field under another Agreement in the anothers Know-How and the anothers patent Rights relating to the Compounds in the Territory, with the right to grants sublicenses.
Product 220,075 shall mean , the twice daily oral formulation(s} using the Intellectual Property and incorporating the compound 220,075 (bicifadine- analgesic) utilizing the Technologies.
Product 273,547 shall mean the once daily oral formulation using the Intellectual Property and incorporating the compound 273,547 (nonbenzodiazapinen anxiolytic) utilizing the Technologies.
IP relates to a controlled release formulations of bicifadine for the treatment of pain and ocinaplon for the treatment of anxiety disorders and epilepsy.